UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 17, 2019

 

 

BIOHITECH GLOBAL, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 001-36843 46-233496
(State of Organization)  (Commission File Number)  (I.R.S. Employer Identification No.)

 

80 Red Schoolhouse Road, Suite 101, Chestnut Ridge, NY 10977

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: 845-262-1081

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Merger Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Merger Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Merger Act (17 CFR 240.13e-4(c))

 

  Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0001 par value per share BHTG NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a)       On July 17, 2019, BioHiTech Global, Inc., a Delaware corporation (the “Company”), held its 2018 Annual Meeting of Stockholders (the “Meeting”). Of the 14,907,956 shares of common stock entitled to vote at the Meeting, 12,919,033 shares of common stock were present in person or by proxy and entitled to vote, representing approximately 86.7% of the Company’s outstanding voting capital stock.

 

(b)       At the Meeting, the Company’s stockholders: (i) re-elected Frank E. Celli, James D. Chambers, Anthony Fuller, Robert A. Graham, Harriet Hentges, and Douglas VanOort as members of the Board of Directors, each for a one-year term expiring at the 2019 annual meeting of stockholders and until each of their respective successors are duly elected and qualified or until each of their respective earlier resignation or removal; (ii) ratified the appointment of Marcum, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019. Each proposal is described in more detail in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 29, 2019.

 

The voting results of the shares of common stock for each proposal are set forth below:

 

Proposal 1 – Election of All Directors:

 

Total Shares Voted Total Votes Withheld

Broker

Non-Votes

7,164,006 0 5,755,027

 

Re-election of Frank E. Celli as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,063,248 100,758 98.59%

 

Re-election of James D. Chambers as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,060,868 103,138 98.56%

 

Re-election of Anthony Fuller as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,065,905 98,101 98.63%

 

Re-election of Robert A. Graham as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,063,218 100,788 98.59%

 

Re-election of Harriet Hentges as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,042,077 121,929 98.30%

 

 

 

 

Re-election of Douglas VanOort as a Director:

 

Votes For Votes Withheld Percentage
Voted For
7,064,313 99,693 98.61%

 

Proposal 2 - To ratify the appointment of Marcum, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019:

 

Votes For Votes Against Votes Abstained Percentage
Voted For

Broker

Non-Votes

12,650,796 113,083 155,154 97.92% 0

 

 

 

SIGNATURES

 

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

 

Date: July 22, 2019 BIOHITECH GLOBAL, INC.  
     
     
  By: /s/ Brian C. Essman  
    Name: Brian C. Essman
    Title:   Principal Financial and Accounting Officer